Dexter Biochem Profile
Key Indicators
- Authorised Capital ₹ 2.30 Cr
as on 07-07-2024
- Paid Up Capital ₹ 2.25 Cr
as on 07-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.26 Cr
as on 07-07-2024
- Satisfied Charges ₹ 11.50 Cr
as on 07-07-2024
- Revenue 13.32%
(FY 2023)
- Profit -14.15%
(FY 2023)
- Ebitda -16.50%
(FY 2023)
- Net Worth 2.57%
(FY 2023)
- Total Assets 1.55%
(FY 2023)
About Dexter Biochem
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.30 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹3.26 Cr. The company has closed loans amounting to ₹11.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rehank Patel, Raghav Dobaria, Rameshbhai Virani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24120GJ2012PTC069603
- Company No.
069603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ankleshwar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dexter Biochem Private Limited offer?
Dexter Biochem Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Insecticides, Termiticide, Acaricide, Cypermethrin, Acetamiprid, Selective Herbicide, Imidacloprid.
Who are the key members and board of directors at Dexter Biochem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ambikesh Padhya  | Director | 18-May-2017 | Current |
| Rehank Patel | Director | 24-Jan-2015 | Current |
| Raghav Dobaria | Director | 27-Mar-2012 | Current |
| Rameshbhai Virani | Director | 27-Mar-2012 | Current |
Financial Performance of Dexter Biochem.
Dexter Biochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.32% increase. The company also saw a substantial fall in profitability, with a 14.15% decrease in profit. The company's net worth moved up by a moderate rise of 2.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dexter Biochem?
In 2023, Dexter Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Aug 2017 | ₹3.26 Cr | Open |
| Creation Date: 09 Mar 2013 | ₹5.00 Cr | Satisfied |
Dena Bank Creation Date: 09 Mar 2013 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Dexter Biochem?
Dexter Biochem has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dexter Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dexter Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
